A clinical study of chronic eosinophilic pneumonia (CEP) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Bronchiolitis obliterans-organizing pneumonia: a series of 26 patients observed over 5 years Source: Eur Respir J 2002; 20: Suppl. 38, 63s Year: 2002
Characterisation of patients with chronic hypersensitivity pneumonitis (CHP) - a seven year single centre experience Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020
Severe community acquired pneumonia (CAP) in ventilated elderly: a 12 yr experience Source: Eur Respir J 2002; 20: Suppl. 38, 475s Year: 2002
Severity before or at the onset of acute exacerbation (AE) can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs)? Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020
Community acquired pneumonia (CAP) in children over 3 years old - etiology, antibiotic sensitiveness and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Problem of bronchiectasis in children: 25 years period of experience Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008
Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005
Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials Source: International Congress 2016 – Asthma management Year: 2016
Pulmonary thromboembolism in HIV (+) patients under 50 years old: a six year study Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Variation in acute exacerbation rates (AER) of COPD over 5 years Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013
Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB) Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006
Respiratory system findings of chronic granulomatous disease in children; 18 years of experience in Turkey Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003
ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Acute exacerbations of interstitial lung diseases:experience of 6 years from a portuguese hospital center Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020
Community acquired pneumonia: What has changed in 10 years? Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010